Programmed Erythrocyte Death Following in Vitro Treosulfan Treatment

Programmed Erythrocyte Death Following in Vitro Treosulfan Treatment

Background/Aims: The cytotoxic drug Treosulfan is clinically used for the treatment of malignancy. A common side effect of Treosulfan treatment is anemia. Treosulfan is at least partially effective by triggering apoptosis of tumor cells. Similar to apoptosis of nucleated cells, erythrocytes may ente...

Full description

Bibliographic Details
Main Authors: Thomas Peter, Rosi Bissinger, Sigrid Enkel, Kousi Alzoubi, Gergely Oswald, Florian Lang
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2015-02-01
Series:Cellular Physiology and Biochemistry
Subjects:
Calcium
Cell volume
Eryptosis
Phosphatidylserine
Reactive oxidant species
Online Access:http://www.karger.com/Article/FullText/373958

Internet

http://www.karger.com/Article/FullText/373958

Similar Items